Apex Healthcare Berhad (KLSE:AHEALTH)

Market Cap	1.53B
Revenue (ttm)	961.78M
Net Income (ttm)	76.54M
Shares Out	720.23M
EPS (ttm)	0.11
PE Ratio	19.81
Forward PE	17.97
Dividend	0.09 (4.25%)
Ex-Dividend Date	May 30, 2025

Volume	20,000
Average Volume	101,505
Open	2.130
Previous Close	2.120
Day's Range	2.120 - 2.130
52-Week Range	1.980 - 3.420
Beta	0.38
RSI	43.24
Earnings Date	May 21, 2025

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates through three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, o...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2024, Apex Healthcare Berhad's revenue was 961.78 billion, an increase of 2.74% compared to the previous year's 936.17 billion. Earnings were 76.54 billion, a decrease of -80.77%.